The revolutionary treatment against cellulite

The revolutionary treatment against cellulite

Cellulite is one of the great aesthetic problems that afflicts millions of women in the world and consists of mild chronic inflammation and stasis of the microcirculation and formation of fibrous shoots that cause skin retractions and irregularities, especially in the gluteal region and thighs, better known as “skin a Orange peel”. The cause of the formation of this imperfection is certainly multifactorial: a genetic predisposition, a very sedentary life, an incorrect diet, the abuse of alcohol and coffee, and many other causes not yet known. Over the years, numerous techniques have been used to improve this cosmetic defect, but with little success. Also in Italy, a new technique for the elimination of cellulite has finally arrived: it is called Cellfina and involves the use of a device approved by the Food and Drug Administration, the US national agency that decides in matters of food, drugs and medical devices. How does the Cellfina treatment against cellulite work? Cellfina acts against the causes that determine what is commonly called the “mattress effect”, ie that ugly imperfection due to the traction that the connective fibers exert on the skin of the thighs and buttocks. The FDA certifies that the system is capable of giving lasting results and, through this device, even plastic surgeons can act on the structural root cause of cellulite. The Cellfina treatment is performed in the clinic and under local anesthesia and the patient can return to his activities within the next 24 hours. The device used must be applied to the part to be treated: in this way, through a slight suction, it raises the tissues by a few millimeters. Subsequently, a thin needle is inserted that spreads the local anesthesia and, as soon as this has taken effect, a larger diameter needle is introduced and activated which cuts the connective fibers present between the sclerotic tissues and the fat. The results are visible already after three days and the controls at 2 years confirm the resistance of the treatment over time.